Exos Asset Management’s Humacyte Inc Warrant HUMAW Stock Holding History

Exos Asset Management’s Portfolio HUMAW Stock Details HUMAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$24K	Hold	27,151	–	–	0.01%	243
2022 Q1	$53K	Hold	27,151	–	–	0.02%	250
2021 Q4	$62K	Sell	27,151 -9,900	-27%	-$28.9K	0.03%	280
2021 Q3	$107K	Sell	37,051 -21,232	-36%	-$62.2K	0.06%	287
2021 Q2	$163K	Buy	58,283 +43,085	+283%	+$114K	0.08%	297
2021 Q1	$45K	Buy	+15,198	New	+$35.9K	0.04%	303

Other funds holding HUMAW

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

Exos Asset Management's HUMAW Position: Q2 2022 in Review

Exos Asset Management held its Humacyte Inc Warrant (HUMAW) position steady in Q2 2022 at 27,151 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #243.

Exos Asset Management first reported a position in HUMAW in Q1 2021 and has held it in 6 quarters since. The position peaked at $163K in Q2 2021. 12 funds tracked by Wall St. Rank hold HUMAW as of Q2 2022.

Exos Asset Management held 27,151 shares of Humacyte Inc Warrant worth $24K as of Q2 2022.
Exos Asset Management left its Humacyte Inc Warrant share count unchanged in Q2 2022.
Humacyte Inc Warrant made up 0.01% of Exos Asset Management's portfolio in Q2 2022, its #243 holding.
Exos Asset Management first reported a position in Humacyte Inc Warrant in Q1 2021 and has held it in 6 quarters since.
Exos Asset Management's Humacyte Inc Warrant position peaked at $163K in Q2 2021.
12 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.